Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39329

DNAJC6 Knockout MES-OV Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Ovary

  • Disease:

    Ovarian serous cystadenocarcinoma

DNAJC6 Knockout MES-OV Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting the DNAJC6 gene in the mesenchymal MES-OV ovarian cancer line. DNAJC6 encodes auxilin, a co-chaperone that recruits Hsc70 to disassemble clathrin coats during endocytosis, regulating receptor recycling and signaling attenuation. This loss-of-function model is ideal for investigating clathrin-mediated endocytosis, receptor trafficking, and signal transduction in ovarian cancer, with applications in EMT, drug resistance, and drug delivery studies. Common assays include EGFR internalization, transferrin uptake, and co-immunoprecipitation with Hsc70.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    MES-OV

    Sex of Donor

    Female

    Age

    53 years

    Derived From Site

    Ascites

    Gene Name

    DNAJC6

    Gene Identifier

    NCBI Gene ID 9829

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    McCoy's 5A

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAJC6 Knockout MES-OV Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the MES-OV human ovarian cancer cell line, engineered to disrupt the DNAJC6 gene. This heterogeneous pool provides a loss-of-function model for studying auxilin-dependent cellular processes, with the polyclonal format offering a robust and representative population for downstream analyses.

The MES-OV cell line originates from a human ovarian adenocarcinoma and exhibits a mesenchymal morphology, making it a widely used model for investigating ovarian cancer metastasis, epithelial-mesenchymal transition (EMT), and drug resistance. Its mesenchymal characteristics facilitate studies of cell migration, invasion, and plasticity, relevant to aggressive cancer phenotypes.

DNAJC6 encodes auxilin, a neuronal J-domain co-chaperone that recruits Hsc70 (HSPA8) to clathrin-coated vesicles, driving clathrin lattice disassembly and vesicle uncoating after endocytosis. This process is essential for recycling synaptic vesicles and receptors. Auxilin interacts with clathrin heavy chain and the AP-2 adaptor complex, and its activity is regulated by PACSIN proteins and neuronal activity. Downstream, auxilin-mediated uncoating promotes early endosome formation, receptor recycling, and signaling attenuation. The clathrin-mediated endocytosis pathway includes clathrin triskelion, AP2 adaptor, Hsc70 co-chaperone, and accessory proteins like synaptojanin 1.

In ovarian cancer cells, clathrin-mediated endocytosis governs internalization of growth factor receptors such as EGFR, thereby modulating signal transduction, proliferation, and migration. Disruption of DNAJC6 in the MES-OV background may impair clathrin uncoating, leading to altered receptor trafficking and signaling dynamics. This model enables dissection of auxilin??s non-neuronal roles in endocytic regulation within a mesenchymal cancer context, potentially linking endocytic dysfunction to EMT and drug resistance mechanisms.

The DNAJC6 Knockout MES-OV Polyclonal Cells are suitable for investigating clathrin-mediated endocytosis, auxilin function in ovarian cancer, receptor trafficking, and signal transduction. Researchers can employ western blotting to assess auxilin levels, immunofluorescence to visualize clathrin dynamics, transferrin uptake and EGFR internalization assays to quantify endocytosis, co-immunoprecipitation to study interactions with Hsc70, and flow cytometry to measure surface receptor expression. Transcriptomic analyses via RT-qPCR or RNA-seq can further elucidate DNAJC6-dependent pathways. For technical support or ordering information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)